Region: Africa & Middle East

Moderna’s covid-19 patent pledge may be backfiring

Though a short-term PR success, the company’s commitment risks looking hollow after its decision not to license know-how to new WHO Africa tech-transfer hub

15 October 2021

Moderna’s covid-19 IP pledge is about to be put to the test

The WHO’s African vaccine hub is seeking to imitate the company’s jab, but an agreement has yet to be reached

24 September 2021

IAM Patent 1000 insights

Featured in Special Report 2021 Q3: IP leadership - what it is and why it matters

09 September 2021

How South Africa’s AI patent was granted and why it is so vulnerable to attack

The applicant cleared its path to success by circumventing any basis for interrogation of the identity of the inventor but that leaves the resulting IP highly exposed in the case of a challenge

30 July 2021

South Africa awards world’s first AI-invented patent, but it may not be that big a deal

The country's IP office does not subject applications to substantive examination meaning grants are virtually guaranteed if formalities are complied with

28 July 2021

The IP Hall of Fame inductees for 2021 announced

Florent Gevers, Andrei Iancu, Fritz Lanham, Dan McCurdy and Laura Quatela are the five individuals selected for induction this year by the IP Hall of Fame Academy

06 July 2021

Time is running out to help choose the IP Hall of Fame inductees for 2021

Nomination process has just a week to go, then the Academy makes its picks

08 April 2021

Another brick in the wall towards patents becoming fully-fledged assets

Announcing the creation of SPIF - a non-partisan, open standard, human readable solution for uniquely identifying patent assets that is consistent with existing formats

18 March 2021

Africa’s mobile phone king ramps up IP filings

Shenzhen-based Transsion has dedicated more resources to patents since its 2019 IPO, but still lags far behind rivals

19 February 2021

Six life sciences IP dealmaking trends to watch out for in 2021

Despite a turbulent 2020 for pharma transactions, it is possible to discern a few patterns for activity in the market this year

19 January 2021